A Pilot Study of Systematic Colorectal Cancer Screening Using FIT in Primary Care: A Single-Center Study in the Nepalese Population
Abstract
Introduction: Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most common cancer in Nepal. The global burden of CRC is increasing in Low- and Middle-income Countries (LMIC), creating a significant public health concern. Therefore, it is high time to implement screening programs that help reduce the rising incidence of CRC. Since there is no published research on systematic CRC Screening (CRCS) programs in Nepal, Gurkha Welfare Trust Nepal (GWTN) aimed to collect and analyze data from a newly introduced screening service and share these with other healthcare professionals in Nepal and globally.
Objectives: The primary goal of this study is to document the uptake of CRCS, measure positive FIT test results, record the outcomes of the positive findings, and evaluate the subjective experiences of medical staff and patient participants.
Material and methods: This is a prospective mixed-method study conducted at the GWTN from October 2024 to December 2024. The study included patients aged 45 to 85 years. The screening method used was a stool sample tested for occult blood via a Fecal Immunochemical Test (FIT). All FIT-positive patients were referred to a tertiary center for colonoscopy, with guidance to follow up within one week of receiving the colonoscopy report. A structured set of questionnaires was administered to 70 randomly selected patients to inquire about their prior knowledge of CRCS, participation, awareness, and overall experience. A different set of structured questionnaires was distributed to the staff to evaluate their subjective experience. All data were initially recorded in Microsoft Excel and later analyzed using the Statistical Package for Social Science (SPSS).
Results: A total of 1,166 patients were counseled for CRCS, of which 1,029 (88.23%) provided a sample. Among these, 105 (10.2%) had FIT-positive results. Of the FIT-positive patients, 90 (85.7%) underwent colonoscopy. 36 (40%) Patients had a normal colonoscopy. Hemorrhoids were observed in 29 (32.2%) patients and terminal ileitis in 3 ( 3.7%) patients. Notably, 24 (26.6%) had colonic polyps and 5 (5.5%) had rectal polyps, findings of clinical significance. Of the 24 colonic polyps, 12 (50%) were tubular adenomas (2 high grade, 10 low grade), 4 (16.6%) had low-grade tubulovillous adenomas, 5 (20.8%) had inflammatory polyps, and 1 (4.1%) had a hyperplastic polyp.
A total of 70 patients were interviewed to explore their awareness and understanding of CRCS. While 32.9% had heard of CRCS previously, only 11.4% were aware of the available screening options, and 20% had previously undergone screening. Despite this, 100% expressed willingness to participate in the future and to recommend it to peers, with nearly all rating their experience as very good.
Fifteen GWTN healthcare staff involved in CRCS were questioned on their subjective experiences. The majority of staff reported having clear guidelines, strong teamwork, and a positive impact from the CRCS program on patient outcomes. Some noted stress levels and administrative burdens, particularly in remote settings. Overall, staff expressed high satisfaction and found the program meaningful.
Conclusions: The CRCS program demonstrated high participation and diagnostic yield, with notable detection of adenomatous polyps and other relevant findings. Feedback from both patients and staff highlighted strong acceptance, satisfaction, and perceived value of the screening initiative.
Full text article
References
WHO. Colorectal cancer. 2023. https://www.who.int/news-room/fact-sheets/detail/colorectal-cancer.
Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023 Feb;72(2):338–44. https://gut.bmj.com/content/72/2/338
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May 4;71(3):209–49. https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660
Mohamad Amin Pourhoseingholi. Epidemiology and burden of colorectal cancer in Asia-Pacific region: what shall we do now? 2014 Oct 22 [cited 2025 Mar 22];3(4). https://tgc.amegroups.com/article/view/4445/5581
Shrestha G, Khanal S, Mulmi R, Sapkota G. Five-year trend of colorectal cancer incidence in B.P. Koirala Memorial Cancer Hospital of Central Nepal: a cross-sectional study. International Journal of Surgery: Global Health. 2020 Nov;3(6):e30–e30. https://journals.lww.com/ijsgh/fulltext/2020/11010/five_year_trend_of_colorectal_cancer_incidence_in.1.aspx
Magar CBP, Bhatta RR, Pandey G, Uprety S, Dhungana I, Jha N. An Overview of Colorectal Cancer in Tertiary care Cancer Center of Nepal. Nepalese Journal of Cancer. 2022 Oct 6;6(2):40–5. https://www.nepjol.info/index.php/njc/article/view/48766
Khatiwada S, Belbase NP, Timilsina B, Yadav P, Bhujel S, Shrestha N, et al. Clinicopathological Profile of Colorectal Cancers in a Tertiary Care Hospital of Central, Nepal. Journal of College of Medical Sciences-Nepal. 2023 Jun 30;19(2):159–66. https://www.nepjol.info/index.php/JCMSN/article/view/55980
Recommendations on screening for colorectal cancer in primary care. Can Med Assoc J. 2016 Mar 15;188(5):340–8. https://pubmed.ncbi.nlm.nih.gov/26903355/
https://www.health.gov.au. Australian Government, Department of Health and Aged Care. 2024. Who should do the bowel screening test. https://www.health.gov.au/our-work/national-bowel-cancer-screening-program/doing-a-bowel-screening-test/who-should-do-the-bowel-screening-test
NZ Ministry of Health. https://www.cancer.org.nz/about-us/our-advocacy-work/position-statements/bowel-screening/. 2025. Bowel Screening Program. https://www.cancer.org.nz/about-us/our-advocacy-work/position-statements/bowel-screening/
NHS. https://www.nhs.uk/conditions/bowel-cancer-screening/. 2024. Bowel cancer screening. https://www.nhs.uk/tests-and-treatments/bowel-cancer-screening/
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for Colorectal Cancer. JAMA. 2021 May 18;325(19):1965. https://pubmed.ncbi.nlm.nih.gov/34003218/
Ding H, Lin J, Xu Z, Chen X, Wang HHX, Huang L, et al. A Global Evaluation of the Performance Indicators of Colorectal Cancer Screening with Fecal Immunochemical Tests and Colonoscopy: A Systematic Review and Meta-Analysis. Cancers (Basel). 2022 Feb 21;14(4):1073. https://pubmed.ncbi.nlm.nih.gov/35205821/
Kapidzic A, van der Meulen MP, Hol L, van Roon AHC, Looman CWN, Lansdorp-Vogelaar I, et al. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia. Clinical Gastroenterology and Hepatology. 2015 Aug;13(8):1464-1471.e4. https://pubmed.ncbi.nlm.nih.gov/25724706/
Sarakarn P, Promthet S, Vatanasapt P, Tipsunthonsak N, Jenwitheesuk K, Maneenin N, et al. Preliminary Results: Colorectal Cancer Screening Using Fecal Immunochemical Test (FIT) in a Thai Population Aged 45-74 Years: A Population-Based Randomized Controlled Trial. Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2883–9. https://pmc.ncbi.nlm.nih.gov/articles/PMC5747418/
Xiaojuan Li MHZWML& YC. Prevalence of diverse colorectal polyps and risk factors for colorectal carcinoma in situ and neoplastic polyps. J Transl Med. 2024 Apr 17;22:361. https://pubmed.ncbi.nlm.nih.gov/38632639/
Norouzi A, Besharat S, Isapanah Amlashi F, Nasrabadi M, Gharanjik I, Ashkbari A, et al. Detection Rate of Colorectal Polyps in Symptomatic Candidates of Colonoscopy: When Should We Do a Total Colonoscopy? Middle East J Dig Dis. 2021 Oct;13(4):314–20. https://pmc.ncbi.nlm.nih.gov/articles/PMC9489442/
Abdelnaby HB, Abuhussein AA, Fouad AM, Alhashash WA, Aldousari AS, Abdelaleem AM, et al. Histopathological and epidemiological findings of colonoscopy screening in a population with an average risk of colorectal cancer in Kuwait. Saudi J Gastroenterol. 2021;27(3):158–65. https://pubmed.ncbi.nlm.nih.gov/33642352/
Ebner DW, Rushlow D, Mou J, Porter K, Finney Rutten LJ, Limburg P, et al. Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids. Mayo Clin Proc Innov Qual Outcomes. 2023 Aug;7(4):320–6. https://pubmed.ncbi.nlm.nih.gov/37502338/
Peery AF, Sandler RS, Galanko JA, Bresalier RS, Figueiredo JC, Ahnen DJ, et al. Risk Factors for Hemorrhoids on Screening Colonoscopy. PLoS One. 2015;10(9):e0139100. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0139100
Hatamian S, Hadavandsiri F, Momenimovahed Z, Salehiniya H. Barriers and facilitators of colorectal cancer screening in Asia. Ecancermedicalscience. 2021 Sep 13;15. https://pubmed.ncbi.nlm.nih.gov/34824608/
Lee J, Ewing B, Holmes D. Barriers and Facilitators to Colorectal Cancer Screening in South Asian Immigrants: A Systematic Review. Asian Pacific Journal of Cancer Prevention. 2023 May 1;24(5):1463–75. https://pubmed.ncbi.nlm.nih.gov/37247265/
Jepson R, Weller D, Alexander F, Walker J. Impact of UK colorectal cancer screening pilot on primary care. Br J Gen Pract. 2005 Jan;55(510):20–5. https://pubmed.ncbi.nlm.nih.gov/15667761/
Wu W, Huang J, Wong MCS, Xu W. Reducing workloads of public health workers in organised colorectal cancer screening in China. Eur J Cancer Care (Engl). 2022 Sep 22;31(5). https://pubmed.ncbi.nlm.nih.gov/35316857/
Ruco A, Khalil A, Ledwos C, Tinmouth J, Kiran T, Lofters A. Exploring barriers and enablers to implementation of cancer screening among primary care professionals seeing marginalized patients. BMC Public Health. 2025 Apr 28;25(1):1578. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-025-22835-9
Authors
Copyright (c) 2025 Journal of Current Medical Research and Opinion

This work is licensed under a Creative Commons Attribution 4.0 International License.